Computer simulations of case difficulty in digital breast tomosynthesis using virtual clinical trials
- PMID: 35212403
- DOI: 10.1002/mp.15553
Computer simulations of case difficulty in digital breast tomosynthesis using virtual clinical trials
Abstract
Purpose: Virtual clinical trials (VCTs) require computer simulations of representative patients and images to evaluate and compare changes in performance of imaging technologies. The simulated images are usually interpreted by model observers whose performance depends upon the selection of imaging cases used in training evaluation models. This work proposes an efficient method to simulate and calibrate soft tissue lesions, which matches the detectability threshold of virtual and human readings.
Methods: Anthropomorphic breast phantoms were used to evaluate the simulation of four mass models (I-IV) that vary in shape and composition of soft tissue. Ellipsoidal (I) and spiculated (II-IV) masses were simulated using composite voxels with partial volumes. Digital breast tomosynthesis projections and reconstructions of a clinical system were simulated. Channelized Hotelling observers (CHOs) were evaluated using reconstructed slices of masses that varied in shape, composition, and density of surrounded tissue. The detectability threshold of each mass model was evaluated using receiver operating characteristic (ROC) curves calculated with the CHO's scores.
Results: The area under the curve (AUC) of each calibrated mass model were within the 95% confidence interval (mean AUC [95% CI]) reported in a previous reader study (0.93 [0.89, 0.97]). The mean AUC [95% CI] obtained were 0.94 [0.93, 0.96], 0.92 [0.90, 0.93], 0.92 [0.90, 0.94], 0.93 [0.92, 0.95] for models I to IV, respectively. The mean AUC results varied substantially as a function of shape, composition, and density of surrounded tissue.
Conclusions: For successful VCTs, lesions composed of soft tissue should be calibrated to simulate imaging cases that match the case difficulty predicted by human readers. Lesion composition, shape, and size are parameters that should be carefully selected to calibrate VCTs.
Keywords: anthropomorphic breast phantom; digital breast tomosynthesis; virtual clinical trials.
© 2022 American Association of Physicists in Medicine.
Comment in
-
In reply to Glick.Med Phys. 2022 Dec;49(12):7371-7372. doi: 10.1002/mp.15950. Epub 2022 Dec 5. Med Phys. 2022. PMID: 36468247 No abstract available.
-
In Regards to Barufaldi et al. Med Phys 49(4), 2220-2232.Med Phys. 2022 Dec;49(12):7369-7370. doi: 10.1002/mp.15771. Epub 2022 Dec 5. Med Phys. 2022. PMID: 36468268 No abstract available.
References
REFERENCES
-
- Abadi E, Segars WP, Tsui BMW, et al. Virtual clinical trials in medical imaging: A review. J Med Imaging. 2020;7(4):042805-1-40. http://doi.org/10.1117/1.JMI.7.4.042805.
-
- Mackenzie A, Thomson EL, Mitchell M, et al. Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging. Eur Radiol. 2021;32(2):806-814. http://doi.org/10.1007/s00330-021-08197-x.
-
- Vancoillie L, Marshall N, Cockmartin L, Vignero J, Zhang G, Bosmans H. Verification of the accuracy of a hybrid breast imaging simulation framework for virtual clinical trial applications. J Med Imaging. 2020;7(04): 042804. http://doi.org/10.1117/1.jmi.7.4.042804.
-
- Cockmartin L, Marshall NW, Van Ongeval C, et al. Comparison of digital breast tomosynthesis and 2D digital mammography using a hybrid performance test. Phys Med Biol. 2015;60(10):3939. http://doi.org/10.1088/0031-9155/60/10/3939.
-
- Barufaldi B, Maidment ADA, Dustler M, et al. Virtual clinical trials in medical imaging system evaluation and optimisation. Radiat Prot Dosimetry. 2021;195(3-4):363-371. http://doi.org/10.1093/rpd/ncab080.
MeSH terms
Grants and funding
- NIH R01 CA154444/the 2020 AAPM Research Seed Grant
- NIH R01 EB018958/the 2020 AAPM Research Seed Grant
- Komen IIR13262248/the 2020 AAPM Research Seed Grant
- IF 846540/EU Horizon 2020 Marie Skłodowska-Curie Action Fellowship IF 846540 Marie Sklodowska Curie Action Fellowship
- BWF IRSA 1016451/EU Horizon 2020 Marie Skłodowska-Curie Action Fellowship IF 846540 Marie Sklodowska Curie Action Fellowship
LinkOut - more resources
Full Text Sources
Medical